Breast Scan Harley Street
Revolutionising Women’s Health
Diagnostics in London

We are
Breast Scan Limited we are visionary private healthcare provider based in London’s Harley Street Medical District.
We are committed to transforming how breast and women’s
health diagnostics are delivered — with compassion, speed, and precision.
Founded by Professor Sam Lingam and a multidisciplinary clinical leadership team, Breast Scan is driven by a mission to make the UK a global leader in preventative healthcare — with Harley Street as its international flagship.
We are
Different

Collaboration & Community
We proudly collaborate with leading consultants, visiting specialists, and Affinity Biomarker Labs to provide comprehensive diagnostics.
We are also actively involved in Hosting international medical symposia (e.g., Breast Cancer Symposium 2024 & 2025).
Partnering with LIMS (London International Medical School) for education and research.
Supporting clinicians via the Harley Street Doctors Organization.

Leadership Team

Prof Sam Lingam
Executive Medical Director -Breastscan
Professor Lingam is a distinguished leader in the field of paediatrics, neurology, and medical education, with a career spanning over five decades and global recognition for his expertise. As Executive Medical Director and Dean at the London International Medical School and Harley Med Clinic, he has contributed groundbreaking research, advanced patient care, and innovative teaching methods shaping the future of healthcare. His compassionate approach aligns seamlessly with Breast Scan’s vision of combining cutting-edge technology and patient-first care. Driven by a passion for both innovation and empathy, Professor Lingam’s ongoing journey involves mentoring future clinicians, shaping international standards in healthcare, and promoting advances such as true 3D breast imaging at Breast Scan. His remarkable dedication ensures every patient benefits not only from the best medical technology, but also the highest standards of care and understanding that Breast Scan stands for.

Chris Moriarty
Executive Director -Breastscan
At the core of our leadership is Chris Moriarty, based in London, UK. Chris brings extensive expertise in advancing scientific innovation and guiding teams dedicated to improving patient outcomes through cutting-edge diagnostics and biomarker research.
Before leading Affinity Biomarker Labs, Chris held influential roles at Fusion Antibodies Plc, Randox Laboratories, and OFL Limited. These experiences provided him with a strong foundation in scientific development, operational leadership, and commercial growth within the life sciences sector. Chris is a graduate of Queen’s University Belfast, where he studied from 1994 to 1997. Over the years, he has built a deep professional skill set spanning life sciences, biotechnology, medical devices, personalized medicine, and immunoassays. His leadership continues to shape our mission of advancing healthcare through innovation and precision.